StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 18, 2026Score 4/30
$0.51+0.01 (+2.18%)

Close on Nov 18, 2026Market cap $21.98MP/E –Yield –

China Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

China Pharma's free cash flow for the twelve months ending Dec 31, 2025 was $88.94K. For fiscal 2025 it was $88.94K. Over ten years it grew -31.7% a year on average. The highest annual figure on record is $27.39M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.94K–
FY2024Dec 31, 2024-$444.47K–
FY2023Dec 31, 2023-$711.20K–
FY2022Dec 31, 2022-$811.51K–
FY2021Dec 31, 2021-$687.89K–
FY2020Dec 31, 2020-$909.57K-292.6%
FY2019Dec 31, 2019$472.31K-74.2%
FY2018Dec 31, 2018$1.83M+159.8%
FY2017Dec 31, 2017$704.74K-73.9%
FY2016Dec 31, 2016$2.70M-33.0%
FY2015Dec 31, 2015$4.04M+294.0%
FY2014Dec 31, 2014$1.02M-96.3%
FY2013Dec 31, 2013$27.39M+620.7%
FY2012Dec 31, 2012$3.80M-32.0%
FY2011Dec 31, 2011$5.59M-28.8%
FY2010Dec 31, 2010$7.85M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$151.54K-45.7%
Q3 FY2025Sep 30, 2025-$204.97K–
Q2 FY2025Jun 30, 2025$274.37K-55.2%
Q1 FY2025Mar 31, 2025-$132.00K–
Q4 FY2024Dec 31, 2024$279.23K–
Q3 FY2024Sep 30, 2024-$37.73K–
Q4 FY2022Dec 31, 2022$611.86K–
Q3 FY2022Sep 30, 2022-$33.43K–
Q2 FY2022Jun 30, 2022-$509.11K-189.7%
Q1 FY2022Mar 31, 2022-$880.83K–
Q4 FY2021Dec 31, 2021-$205.17K–
Q3 FY2021Sep 30, 2021-$866.82K–
Q4 FY2020Dec 31, 2020$567.44K–
Q3 FY2020Sep 30, 2020-$483.82K-203.4%
Q2 FY2020Jun 30, 2020-$401.24K-203.7%
Q1 FY2020Mar 31, 2020-$591.95K–
Q4 FY2019Dec 31, 2019-$72.37K-108.4%
Q3 FY2019Sep 30, 2019$468.04K-46.8%
Q2 FY2019Jun 30, 2019$386.96K–
Q1 FY2019Mar 31, 2019-$310.33K-159.7%
Q4 FY2018Dec 31, 2018$856.62K-1.3%
Q3 FY2018Sep 30, 2018$879.94K+32.8%
Q2 FY2018Jun 30, 2018-$425.70K–
Q1 FY2018Mar 31, 2018$520.11K–
Q4 FY2017Dec 31, 2017$867.61K-36.5%
Q3 FY2017Sep 30, 2017$662.52K–
Q2 FY2017Jun 30, 2017-$808.52K–
Q1 FY2017Mar 31, 2017-$16.86K–
Q4 FY2016Dec 31, 2016$1.37M–

More China Pharma figures

See a number that looks wrong?